BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 34594304)

  • 1. Role of AMH in Prediction of Menopause.
    de Kat AC; Broekmans FJM; Lambalk CB
    Front Endocrinol (Lausanne); 2021; 12():733731. PubMed ID: 34594304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The physiology and clinical utility of anti-Mullerian hormone in women.
    Dewailly D; Andersen CY; Balen A; Broekmans F; Dilaver N; Fanchin R; Griesinger G; Kelsey TW; La Marca A; Lambalk C; Mason H; Nelson SM; Visser JA; Wallace WH; Anderson RA
    Hum Reprod Update; 2014; 20(3):370-85. PubMed ID: 24430863
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum anti-Mullerian hormone (AMH) concentration has limited prognostic value for density of primordial and primary follicles, questioning it as an accurate parameter for the ovarian reserve.
    von Wolff M; Roumet M; Stute P; Liebenthron J
    Maturitas; 2020 Apr; 134():34-40. PubMed ID: 32143774
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Maternal menopause as a predictor of anti-Mullerian hormone level and antral follicle count in daughters during reproductive age.
    Bentzen JG; Forman JL; Larsen EC; Pinborg A; Johannsen TH; Schmidt L; Friis-Hansen L; Nyboe Andersen A
    Hum Reprod; 2013 Jan; 28(1):247-55. PubMed ID: 23136135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improving Prediction of Age at Menopause Using Multiple Anti-Müllerian Hormone Measurements: the Tehran Lipid-Glucose Study.
    Ramezani Tehrani F; Bidhendi Yarandi R; Solaymani-Dodaran M; Tohidi M; Firouzi F; Azizi F
    J Clin Endocrinol Metab; 2020 May; 105(5):. PubMed ID: 32109280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-Müllerian Hormone and Ovarian Reserve: Update on Assessing Ovarian Function.
    Moolhuijsen LME; Visser JA
    J Clin Endocrinol Metab; 2020 Nov; 105(11):3361-73. PubMed ID: 32770239
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-Müllerian hormone as a predictor of reproductive potential.
    Hawkins Bressler L; Steiner A
    Curr Opin Endocrinol Diabetes Obes; 2018 Dec; 25(6):385-390. PubMed ID: 30299431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Anti Müllerian Hormone: More than a biomarker of female reproductive function.
    Victoria M; Labrosse J; Krief F; Cédrin-Durnerin I; Comtet M; Grynberg M
    J Gynecol Obstet Hum Reprod; 2019 Jan; 48(1):19-24. PubMed ID: 30352309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-Müllerian hormone: ovarian reserve testing and its potential clinical implications.
    Broer SL; Broekmans FJ; Laven JS; Fauser BC
    Hum Reprod Update; 2014; 20(5):688-701. PubMed ID: 24821925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-Mullerian hormone - a marker of upcoming menopause or a questionable guesswork?
    Warzecha D; Szymusik I; Pietrzak B; Wielgos M
    Neuro Endocrinol Lett; 2017 May; 38(2):75-82. PubMed ID: 28650599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Can we predict menopause and premature ovarian insufficiency?
    Laven JSE; Louwers YV
    Fertil Steril; 2024 May; 121(5):737-741. PubMed ID: 38382699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Anti-Müllerian hormone is a clinical useful measure of the ovarian reserve].
    Hyldgaard JM; Ingerslev HJ; Tørring N; Madsen HN; Bor P
    Ugeskr Laeger; 2015 Jan; 177(5):V09140477. PubMed ID: 25650516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-Müllerian hormone as a qualitative marker - or just quantity?
    Kotlyar A; Seifer DB
    Curr Opin Obstet Gynecol; 2020 Jun; 32(3):219-226. PubMed ID: 32205525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical application of serum anti-Müllerian hormone as an ovarian reserve marker: A review of recent studies.
    Iwase A; Osuka S; Goto M; Murase T; Nakamura T; Takikawa S; Kikkawa F
    J Obstet Gynaecol Res; 2018 Jun; 44(6):998-1006. PubMed ID: 29517134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum anti-Mullerian hormone assessment of ovarian reserve and polycystic ovary syndrome status over the reproductive lifespan.
    Tremellen K; Zander-Fox D
    Aust N Z J Obstet Gynaecol; 2015 Aug; 55(4):384-9. PubMed ID: 26230428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-Müllerian hormone: an ovarian reserve marker in primary ovarian insufficiency.
    Visser JA; Schipper I; Laven JS; Themmen AP
    Nat Rev Endocrinol; 2012 Jan; 8(6):331-41. PubMed ID: 22231848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Does the serum AMH assay allow predicting reliably female fertility?].
    Rolland AL; Dewailly D
    Gynecol Obstet Fertil; 2015 Oct; 43(10):670-5. PubMed ID: 26388252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Can we predict age at natural menopause using ovarian reserve tests or mother's age at menopause? A systematic literature review.
    Depmann M; Broer SL; van der Schouw YT; Tehrani FR; Eijkemans MJ; Mol BW; Broekmans FJ
    Menopause; 2016 Feb; 23(2):224-32. PubMed ID: 26372034
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Does anti-Müllerian hormone predict menopause in the general population? Results of a prospective ongoing cohort study.
    Depmann M; Eijkemans MJ; Broer SL; Scheffer GJ; van Rooij IA; Laven JS; Broekmans FJ
    Hum Reprod; 2016 Jul; 31(7):1579-87. PubMed ID: 27179263
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mother's age at menopause but not own age at menarche has an impact on ovarian reserve.
    Moreau J; Gatimel N; Cohade C; Parinaud J; Léandri R
    Gynecol Endocrinol; 2018 Aug; 34(8):664-665. PubMed ID: 29345168
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.